Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform.
Edwin LinAndrew W HahnRoberto H NussenzveigSergiusz WesolowskiNicolas SayeghBenjamin L MaughanTaylor Ryan McFarlandNityam RathiDeepika SirohiGuru SonpavdeUmang SwamiManish KohliThereasa RichOliver SartorMark YandellArchana M AgarwalPublished in: The oncologist (2021)
The progression from castration-sensitive to castration-resistant prostate cancer is characterized by worse prognosis and there is a pressing need for targeted drugs to prevent or delay this transition. This study used machine learning algorithms to examine the cell-free DNA of patients to identify alterations to specific pathways and genes associated with progression. Detection of these alterations in cell-free DNA may overcome the challenges associated with obtaining tumor bone biopsies and allow contemporary investigation of combinatorial therapies that target these aberrations.
Keyphrases
- machine learning
- prostate cancer
- copy number
- artificial intelligence
- end stage renal disease
- ejection fraction
- squamous cell carcinoma
- deep learning
- big data
- genome wide
- radical prostatectomy
- prognostic factors
- high throughput
- patient reported outcomes
- cancer therapy
- loop mediated isothermal amplification
- postmenopausal women
- body composition
- soft tissue
- single cell